Elixirr International Plc (ELIX) - Total Liabilities

Latest as of December 2025: GBX108.56 Million GBX ≈ $13.21K USD

Based on the latest financial reports, Elixirr International Plc (ELIX) has total liabilities worth GBX108.56 Million GBX (≈ $13.21K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Elixirr International Plc (ELIX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Elixirr International Plc - Total Liabilities Trend (2017–2025)

This chart illustrates how Elixirr International Plc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Elixirr International Plc total assets.

Elixirr International Plc Competitors by Total Liabilities

The table below lists competitors of Elixirr International Plc ranked by their total liabilities.

Company Country Total Liabilities
PAVmed Inc
NASDAQ:PAVM
USA $12.28 Million
Murchison Minerals Ltd
V:MUR
Canada CA$252.29K
Sparta Capital Ltd
V:SAY
Canada CA$3.68 Million
Aeeris Ltd
AU:AER
Australia AU$891.79K
Techgen Metals Ltd
AU:TG1
Australia AU$102.12K
Akg Exim Limited
NSE:AKG
India Rs83.70 Million
Social Housing REIT plc
LSE:SOHO
UK GBX266.00 Million
South HARZ Potash Ltd
AU:SHP
Australia AU$1.16 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Elixirr International Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Elixirr International Plc to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.52 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.76 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.43 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Elixirr International Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Elixirr International Plc (2017–2025)

The table below shows the annual total liabilities of Elixirr International Plc from 2017 to 2025.

Year Total Liabilities Change
2025-12-31 GBX108.56 Million
≈ $13.21K
+147.96%
2024-12-31 GBX43.78 Million
≈ $5.33K
+25.67%
2023-12-31 GBX34.84 Million
≈ $4.24K
+6.40%
2022-12-31 GBX32.74 Million
≈ $3.98K
+54.96%
2021-12-31 GBX21.13 Million
≈ $2.57K
+29.55%
2020-12-31 GBX16.31 Million
≈ $1.98K
-50.27%
2019-12-31 GBX32.79 Million
≈ $3.99K
+185.70%
2019-04-30 GBX11.48 Million
≈ $1.40K
-10.34%
2018-04-30 GBX12.80 Million
≈ $1.56K
+26.89%
2017-04-30 GBX10.09 Million
≈ $1.23K
--

About Elixirr International Plc

LSE:ELIX UK Consulting Services
Market Cap
$3.61 Million
GBX29.63 Billion GBX
Market Cap Rank
#29282 Global
#550 in UK
Share Price
GBX608.00
Change (1 day)
+2.01%
52-Week Range
GBX576.00 - GBX896.00
All Time High
GBX896.00
About

Elixirr International plc, through its subsidiaries, provides management consultancy services in the United Kingdom, the United States, and internationally. The company offers digital, data, AI, and transformation services. It also provides services in the areas of AI and machine learning, app design and development, brand identity implementation, brand strategy, breakthrough imperatives, busines… Read more